Antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South Africa

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Peltzer, Karl ^a,b   Friend Du Preez, Natalie ^c   Ramlagan, Shandir ^a   Anderson, Jane ^d  

^a HUMAN SCIENCES RESEARCH COUNCIL   (South Africa)

^b UNIVERSITY OF THE FREE STATE   (South Africa)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; ARTICLE; CHECKLIST; FEMALE; FOLLOW UP; HEALTH STATUS INDICATOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SOCIAL STIGMA; SOCIAL SUPPORT; SOCIOECONOMICS; SOUTH AFRICA; STATISTICS;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; CHECKLIST; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS INDICATORS; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT COMPLIANCE; QUESTIONNAIRES; SOCIAL STIGMA; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS; SOUTH AFRICA;

EID: 77949510366     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-111     Document Type: Article

References (44)

1. Therapeutic drug monitoring of antiretrovirals for people with HIV. T Kredo J Van der Walt N Siegfried K Cohen, Cochrane Database Systematic Review 2009 8 3 D007268
2. Mortality and virologic outcomes after access to antiretroviral therapy among a cohort of HIV-infected women who received single-dose nevirapine in Lusaka, Zambia. L Kuhn K Semrau S Ramachandran M Sinkala N Scott P Kasonde M Mwiya C Kankasa D Decker D Thea G Aldrovandi, J Acquir Immune Defic Syndr 2009 52 1 132 136 10.1097/QAI.0b013e3181ab6d5e 19506483
3. Improved survival in HIV-infected persons: consequences and perspectives. N Lohse A Hansen J Gerstoft N Obel, J Antimicrob Chemother 2007 60 3 461 463 10.1093/jac/dkm241 17609196
4. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. F Pallela K Delaney A Moorman M Loveless J Fuhrer GA Satten DJ Aschman SD Holmberg, N Engl J Med 1998 338 13 853 860 10.1056/NEJM199803263381301 9516219
5. Meta-analytical studies on the epidemiology, prevention, and treatment of human immunodeficiency virus infection. P Vergidis M Falagas D Hamer, Infect Dis Clin North Am 2009 23 2 295 308 10.1016/j.idc.2009.01.013 19393910
6. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals. V Lima R Harrigan M Murray D Moore E Wood R Hogg J Montaner, AIDS 2008 22 2371 2380 10.1097/QAD.0b013e328315cdd3 18981777
7. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viralsuppression. D Bangsberg, Clin Infec Dis 2006 43 7 939 41 10.1086/507526
8. HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. J Shuter J Sarlo T Kanmaz R Rode B Zingman, J Acquir Immune Defic Syndr 2007 45 1 4 8 10.1097/QAI.0b013e318050d8c2 17460469
9. An analysis of electronically monitored adherence to antiretroviral medications. G Knafl C Bova K Fennie J O'Malley K Dieckhaus A Williams, AIDS Behav 2008 10.1007/s10461-008-9512-z 19107587
10. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. E Mills J Nachega D Bangsberg S Singh B Rachlis P Wu K Wilson I Buchan C Gill C Cooper, PLoS Med 2006 3 11 438 10.1371/journal.pmed.0030438 17121449
11. Gender differences in factors associated with adherence to antiretroviral therapy. K Berg P Demas A Howard E Schoenbaum M Gourevitch J Arnsten, J Gen Intern Med 2004 19 11 1111 1117 10.1111/j.1525-1497.2004.30445.x 15566440
12. Gender differences in discontinuation of antiretroviral treatment regimens. M Kempf M Pisu A Dumcheva A Westfall J Md M Saag, J Acquir Immune Defic Syndr 2009 19654551
13. Managing AIDS Stigma. WL Holzemer L Uys, SAHARA J 2004 1 3 165 174 17601004
14. The association of stigma with self-reported access to medical care and antiretroviral therapy adherence in persons living with HIV/AIDS. J Sayles M Wong J Kinsler D Martins W Cunningham, J GenIntern Med 2009
15. Stigma, discrimination and the implications for people living with HIV/AIDS in South Africa. D Skinner S Mfecane, SAHARA J 2004 1 3 157 164 17601003
16. Antiretroviral adherence in rural Zambia: the first year of treatment availability. G Birbeck E Chomba M Kvalsund R Bradbury C Mang'ombe K Malama T Kaile P Byers N Organek RAAZ Study Team, Am J Trop Med Hyg 2009 80 4 669 674 19346397
17. That is why I stopped the ART": patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme. M Dahab S Charalambous R Hamilton K Fielding K Kielmann G Churchyard A Grant, BMC Public Health 2008 8 63 10.1186/1471-2458-8- 63 18282286
18. Patients' adherence to antiretroviral therapy in Botswana. E Kip V Ehlers D van der Wal, J Nurs Scholarsh 2009 41 2 149 157 10.1111/j.1547-5069.2009. 01266.x 19538699
19. Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study. L Murray K Semrau E McCurley D Thea N Scott M Mwiya C Kankasa J Bass P Bolton, AIDS Care 2009 21 1 78 86 10.1080/09540120802032643 19085223
20. Barriers and facilitators to patients' adherence to antiretroviral treatment in Zambia: a qualitative study. N Sanjobo J Frich A Fretheim, SAHARA J 2008 5 3 136 143 18979047
21. A review of health behaviour theories: how useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS? S Munro S Lewin T Swart J Volmink, BMC Public Health 2007 11 7 104 10.1186/1471-2458-7-104
22. An information-motivation-behavioral skills model of adherence to antiretroviral therapy. JD Fisher WA Fisher KR Amico JJ Harman, Health Psychology 2006 25 4 462 473 10.1037/0278-6133.25.4.462 16846321
23. Uthukela (DC 23) district. KwaZulu-Natal Department of Health, 2009 http://www.kznhealth.gov.za/uthukela.htm
24. Use of traditional, complementary and alternative medicine (TCAM) for HIV patients in KwaZulu-Natal, South Africa. K Peltzer N Friend-du Preez S Ramlagan H Fomundam, BMC Public Health 2008 24,8 1 255 10.1186/1471-2458-8-255
25. The revised Sign and Symptom Check-list for HIV (SSC-HIVrev). WL Holzemer A Hudson KM Kirksey MJ Hamilton S Bakken, J Assoc Nurses AIDS Care 2001 12 5 60 70 10.1016/S1055-3290(06)60263-X 11565239
26. WHOQOL-HIV for quality of life assessment among people living with HIV and AIDS: Results from a field test. K O'Connell S Saxena SM Skevington WHOQOL HIV Group, AIDS Care 2004 16 7 882 889 10.1080/09540120412331290194 15385243
27. Initial steps to developing the World Health Organization's Quality of Life Instrument (WHOQOL) module for international assessment in HIV/AIDS. WHOQOL (World Health Organization's Quality of Life HIV Instrument HIV Group, AIDS Care 2003 15 3 347 357 10.1080/0954012031000105405 12745402
28. AUDIT: The Alcohol Use Disorders Identification Test. Guidelines for use in primary care. TF Babor JC Higgens-Biddle JB Saunders MG Monteiro, Geneva: World Health Organization, Department of Mental Health and Substance Dependence. WHO/MSD/MSB/01.6a 2001
29. Screening and brief intervention for hazardous drinking in an HMO: effects on medical care utilization. DK Freeborn RP Polen JF Hollis RA Senft, J Behavioral Health Serv Res 2000 27 446 453 10.1007/BF02287826
30. AUDIT-3 and AUDIT-4: Effectiveness of two short forms of the alcohol use disorders identification test. A Gual L Segura M Contel N Heather J Colom, Alcohol Alcohol 2002 37 6 561 596 12414547
31. Development of a brief scale to measure AIDS-related stigmas in South Africa. SC Kalichman L Simbayi S Jooste Y Toefy D Cain C Cherry, AIDS Behav 2005 9 135 143 10.1007/s10461-005-3895-x 15933833
32. Simultaneous assessment of perceived global and relationship-specific support. D Brock I Sarason B Sarason G Pierce, J Soc Pers Relat 1996 13 143 152 10.1177/0265407596131008
33. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). E Andresen J Malmgren W Carter D Patrick, Am J Prev Med 1994 10 2 77 84 8037935
34. Clinical importance of HIV and depressive symptoms among veterans with HIV infection. A Kilbourne A Justice B Rollman K McGinnis L Rabeneck S Weissman S Smola R Schultz J Whittle M Rodriguez-Barradas, J Gen Intern Med 2002 17 7 512 520 10.1046/j.1525-1497.2002.10803.x 12133141
35. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). MA Chesney JR Ickovics DB Chambers AL Gifford J Neidig B Zwickl AW Wu, AIDS Care 2000 12 3 255 266 10.1080/09540120050042891 10928201
36. Adherence to antiretroviral medication among HIV-positive patients in Thailand. WL Maneesriwongul S Tulathong KP Fennie AB Williams, J Acquir Immune Defic Syndr 2006 43 1 119 S122 10.1097/01.qai.0000248346.79888.78 17133194
37. Promoting adherence to antiretroviral therapy through a directly administered antiretroviral therapy (DAART) strategy in Mombasa, Kenya. A Sarna S Luchters P Geibel S Munyao K Kaai K Shikely, Nairobi: Population Council 2005
38. An information-motivation-behavioral skills model of adherence to antiretroviral therapy. JD Fisher WA Fisher KR Amico JJ Harman, Health Psychol 2006 25 462 473 10.1037/0278-6133.25.4.462 16846321
39. The LifeWindows information-motivation-behavioral skills ART adherence questionnaire. The LifeWindows Project Team, Connecticut, Center for Health, Intervention and Prevention 2006
40. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. E Mills J Nachega I Buchan J Orbinski A Attaran S Singh B Rachlis P Wu C Cooper L Thabane K Wilson G Guyatt D Bangsberg, JAMA 2006 296 6 679 90 10.1001/jama.296.6.679 16896111
41. Public-sector ART in the Free State Province, South Africa: Community support as an important determinant of outcome. E Wouters W Van Dammeb F Van Loon, Soc Sci Med 2009 19692165
42. A simple single-item rating scale to measure medication adherence: further evidence for convergent validity. SC Kalichman CM Amaral C Swetzes M Jones R Macy MO Kalichman C Cherry, J Int Assoc Physicians AIDS Care (Chic Ill) 2009 8 6 367 74 10.1177/1545109709352884 19952289
43. Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities. JB Nachega EJ Mills M Schechter, Curr Opin HIV AIDS 2010 5 1 70 7 10.1097/COH.0b013e328333ad61 20046150
44. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. JM Simoni AE Kurth CR Pearson DW Pantalone JO Merrill PA Frick, AIDS Behav 2006 10 3 227 45 10.1007/s10461-006-9078-6 16783535